Skip to main content

and
  1. Article

    Open Access

    18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

    The Centiloid (CL) method enables quantitative values from Aβ-amyloid (Aβ) imaging to be expressed in a universal unit providing pathological, diagnostic and prognostic thresholds in clinical practice and rese...

    Christopher C. Rowe, Vincent Doré in European Journal of Nuclear Medicine and M… (2017)

  2. No Access

    Article

    In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease

    Diagnosis of tauopathies such as Alzheimer’s disease (AD) still relies on post-mortem examination of the human brain. A non-invasive method of determining brain tau burden in vivo would allow a better understa...

    Victor L. Villemagne, Shozo Furumoto in European Journal of Nuclear Medicine and M… (2014)

  3. Article

    Open Access

    Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies

    The introduction of tau imaging agents such as 18F-THK523 offers new hope for the in vivo assessment of tau deposition in tauopathies such as Alzheimer’s disease (AD), where preliminary 18F-THK523-PET studies hav...

    Michelle T Fodero-Tavoletti, Shozo Furumoto in Alzheimer's Research & Therapy (2014)

  4. Article

    Open Access

    18F-florbetaben Aβ imaging in mild cognitive impairment

    18F-florbetaben and positron emission tomography were used to examine the relationships between β-amyloid (Aβ) deposition, cognition, hippocampal volume, and white matter hyperintensities in mild cognitive impai....

    Kevin Ong, Victor L Villemagne, Alex Bahar-Fuchs in Alzheimer's Research & Therapy (2013)

  5. No Access

    Article

    Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease

    Amyloid imaging with 18F-labelled radiotracers will allow widespread use of this technique, facilitating research, diagnosis and therapeutic development for Alzheimer’s disease (AD). The purpose of this analysis ...

    Victor L. Villemagne, Rachel S. Mulligan in European Journal of Nuclear Medicine and M… (2012)

  6. No Access

    Protocol

    Quantitative Approaches to Amyloid Imaging

    Alzheimer’s disease (AD), an irreversible, progressive neurodegenerative disorder clinically characterized by memory loss and cognitive decline, is the leading cause of dementia in the elderly, leading invaria...

    Victor L. Villemagne, Graeme O’Keefe, Rachel S. Mulligan in Molecular Imaging (2011)

  7. No Access

    Article

    Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET

    Single-photon emission tomography (SPET) and positron emission tomography (PET), when coupled to suitable radioligands, are uniquely powerful for investigating the status of neurotransmitter receptors in vivo....

    Victor W. Pike, Christer Halldin in European Journal of Nuclear Medicine and M… (2003)